Verily, an Alphabet (GOOG) (GOOGL) precision health company, has agreed to sell the company’s Granular insurance business to Elevance Health ...
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a high estimate of $512.00 and a low estimate of $478.00. A decline of 6.69% ...
Verily, Alphabet's life science group, entered an agreement to sell its insurance subsidiary to Elevance Health. In an email to staff last month, Verily CEO Stephen Gillett announced that Granular ...
Elevance Health Stock Down 1.2 % ELV opened at $384.77 on Friday. Elevance Health, Inc. has a twelve month low of $362.21 and a twelve month high of $567.26. The company has a debt-to-equity ratio ...